KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biomarin Pharmaceutical (BMRN) Receivables - Other (2016)

Biomarin Pharmaceutical's Receivables - Other history spans 5 years, with the latest figure at $8.4 million for Q3 2016.

  • For the quarter ending Q3 2016, Receivables - Other changed N/A year-over-year to $8.4 million, compared with a TTM value of $8.4 million through Sep 2016, changed N/A, and an annual FY2013 reading of $116.5 million, changed N/A over the prior year.
  • Receivables - Other for Q3 2016 was $8.4 million at Biomarin Pharmaceutical, down from $116.5 million in the prior quarter.
  • The five-year high for Receivables - Other was $116.5 million in Q4 2013, with the low at $6.8 million in Q1 2012.
  • Average Receivables - Other over 3 years is $30.1 million, with a median of $9.0 million recorded in 2012.
  • Biggest YoY gain for Receivables - Other was 111.9% in 2012; the steepest drop was 23.81% in 2012.
  • Tracing BMRN's Receivables - Other over 3 years: stood at $9.0 million in 2012, then skyrocketed by 1191.86% to $116.5 million in 2013, then crashed by 92.79% to $8.4 million in 2016.
  • Per Business Quant, the three most recent readings for BMRN's Receivables - Other are $8.4 million (Q3 2016), $116.5 million (Q4 2013), and $9.0 million (Q3 2012).